Long-term Study of DSP-5423P in Patients With Schizophrenia
Clinical trial NCT02335658 · COMPLETED
Trial details
- NCT number
- NCT02335658
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-05-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.